title: Evaluation of red blood cell distribution width as a prognostic indicator in cats with acquired heart disease, with and without congestive heart failure.
abstract: Objectives Congestive heart failure secondary to cardiomyopathy is a common manifestation of cardiac disease in cats, carrying a variable prognosis. The objective of this retrospective study was to evaluate the relationship between red blood cell distribution width (RDW) and survival time in feline patients with acquired heart disease with and without congestive heart failure (CHF). Methods Three hundred and forty-nine client-owned cats with echocardiograms and complete blood count, including RDW measurement, performed between March 2006 and December 2011, were included in the study. Patient characteristics, including signalment, hematocrit, RDW, echocardiographic parameters and survival, were recorded. Comparisons between RDW in cats with asymptomatic acquired heart disease and those with CHF were made. Survival was documented and compared at 30 days and 6 months. Results CHF was present in 80 cats and absent in 269 cats. Cats with CHF had an increase in mortality compared with cats without CHF at 30 days and 6 months ( P = 0.007 and P = 0.04, respectively). RDW was not significantly associated with survival in cats with or without CHF at 30 days or 6 months. A significant difference was found between median RDW values in cats with CHF vs cats without CHF (16.3% vs 15.8%; P = 0.02). The median RDW value was significantly higher in cats with unclassified cardiomyopathy compared with cats with other types of cardiomyopathy (16.3% vs 15.8%; P = 0.03). Conclusions and relevance Single RDW values did not predict mortality in cats with acquired heart disease but may be useful in determining if cats have decompensated heart disease and CHF. Human studies indicate that incremental increases in serial RDW measurements are associated with decreased survival; serial RDW measurements in cats may be an area of future study.
authors.affiliation: 1 Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, USA.|2 Angell Animal Medical Center, MA, USA.
authors.forename: Kursten V
authors.initials: KV
authors.lastname: Roderick
authors.affiliation: 1 Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, USA.
authors.forename: Amanda L
authors.initials: AL
authors.lastname: Abelson
authors.affiliation: 2 Angell Animal Medical Center, MA, USA.|3 SAGE Centers, CA, USA.
authors.forename: Lindsey
authors.initials: L
authors.lastname: Nielsen
authors.affiliation: 4 The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, MA, USA.|5 Tufts Clinical and Translational Science Institute, Tufts University, MA, USA.
authors.forename: Lori Lyn
authors.initials: LL
authors.lastname: Price
authors.affiliation: 2 Angell Animal Medical Center, MA, USA.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Quinn
mesh_terms: D000818:Animals; D002312:Cardiomyopathy, Hypertrophic / Q000097:blood / Q000150:complications / Q000662:veterinary*; D002371:Cat Diseases / Q000097:blood* / Q000000981:diagnostic imaging; D002415:Cats; D004452:Echocardiography / Q000662:veterinary; D004909:Erythrocyte Indices / Q000662:veterinary*; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000150:complications / Q000662:veterinary*; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies